l 366948 has been researched along with phenylpropanolamine in 1 studies
*Phenylpropanolamine: A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. [MeSH]
*Phenylpropanolamine: A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. [MeSH]
Studies (l 366948) | Trials (l 366948) | Recent Studies (post-2010) (l 366948) | Studies (phenylpropanolamine) | Trials (phenylpropanolamine) | Recent Studies (post-2010) (phenylpropanolamine) |
---|---|---|---|---|---|
12 | 0 | 0 | 1,861 | 369 | 222 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McMahon, LR; Wellman, PJ | 1 |
1 other study(ies) available for l 366948 and phenylpropanolamine
Article | Year |
---|---|
Assessment of the role of oxytocin receptors in phenylpropanolamine-induced anorexia in rats.
Topics: Animals; Anorexia; Appetite Depressants; Dose-Response Relationship, Drug; Drinking; Eating; Hormone Antagonists; Male; Peptides, Cyclic; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Receptors, Oxytocin | 1997 |